Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain.
Publication
, Journal Article
Ahmad, T; Roe, MT
Published in: Nat Rev Cardiol
August 2014
Duke Scholars
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
August 2014
Volume
11
Issue
8
Start / End Page
440 / 442
Location
England
Related Subject Headings
- Spironolactone
- Myocardial Infarction
- Mineralocorticoid Receptor Antagonists
- Male
- Humans
- Female
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ahmad, T., & Roe, M. T. (2014). Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain. Nat Rev Cardiol, 11(8), 440–442. https://doi.org/10.1038/nrcardio.2014.89
Ahmad, Tariq, and Matthew T. Roe. “Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain.” Nat Rev Cardiol 11, no. 8 (August 2014): 440–42. https://doi.org/10.1038/nrcardio.2014.89.
Ahmad T, Roe MT. Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain. Nat Rev Cardiol. 2014 Aug;11(8):440–2.
Ahmad, Tariq, and Matthew T. Roe. “Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain.” Nat Rev Cardiol, vol. 11, no. 8, Aug. 2014, pp. 440–42. Pubmed, doi:10.1038/nrcardio.2014.89.
Ahmad T, Roe MT. Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain. Nat Rev Cardiol. 2014 Aug;11(8):440–442.
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
August 2014
Volume
11
Issue
8
Start / End Page
440 / 442
Location
England
Related Subject Headings
- Spironolactone
- Myocardial Infarction
- Mineralocorticoid Receptor Antagonists
- Male
- Humans
- Female
- Cardiovascular System & Hematology